Lakewood-Amedex Biotherapeutics, Inc. (LABT)
0.2359
-0.05
(-17.23%)
USD |
NASDAQ |
Oct 29, 16:00
0.2248
-0.01
(-4.71%)
After-Hours: 19:05
Lakewood-Amedex Biotherapeutics Net Income (Quarterly) : -3.772M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.772M |
| March 31, 2026 | -0.9233M |
| December 31, 2025 | -0.7449M |
| September 30, 2025 | -1.907M |
| June 30, 2025 | -0.6559M |
| Date | Value |
|---|---|
| March 31, 2025 | -0.5396M |
| December 31, 2024 | -0.8545M |
| September 30, 2024 | -1.936M |
| June 30, 2024 | -1.061M |
| March 31, 2024 | -1.004M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.772M |
| EPS Diluted (Quarterly) | -1.739 |
| Enterprise Value | -3.865M |
| Earnings Yield | -4.38K% |